DiFabio Andrea 4
4 · Xenon Pharmaceuticals Inc. · Filed Nov 9, 2022
Insider Transaction Report
Form 4
DiFabio Andrea
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-11-07+135,000→ 135,000 totalExercise: $34.77Exp: 2032-11-06→ Common Shares (135,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.